Trial intelligence / Profile preview

Intravenous Artesunate Versus Quinine in Severe Malaria

NCT01805232Phase 4Unknown

Sponsor
University of Khartoum
Start
Mar 2013
Primary completion
May 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of artesunate in malaria, sponsored by University of Khartoum. Status: unknown.

02

Drugs

artesunate
03

Conditions

malaria

Beyond the preview

Go deeper on NCT01805232.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01805232.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call